Aurora Cannabis (ACB) Operating Income (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly Operating Income of $3.0 million for Q1 2026, up 117.78% year-on-year from $1.4 million in Q1 2025, and down 78.77% on a QoQ basis from $14.0 million in Q4 2025.
Aurora Cannabis (ACB) Operating Income (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Operating Income for 10 consecutive years, with $3.0 million the latest figure, recorded in Q1 2026.
- Quarterly Operating Income rose 117.78% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.8 million (up 161.89% YoY) and the FY2026 annual result came in at -$33.8 million, down 1048.62% from the prior year.
- Operating Income eased to $3.0 million in Q1 2026 per ACB's latest filing, from $14.0 million in the prior quarter.
- Over the last five years, Operating Income for ACB reached as high as $26.4 million in Q4 2024 and fell as low as -$4.8 billion in Q2 2023.
- A 5-year average of -$317.1 million and a median of -$4.9 million in 2023 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2023 — Operating Income sank 10000.51% — and 2024, when it surged 304.13%.
- Year by year, Operating Income stood at -$129.2 million in 2022, then soared by 90.0% to -$12.9 million in 2023, then jumped by 304.13% to $26.4 million in 2024, then tumbled by 46.83% to $14.0 million in 2025, then plunged by 78.77% to $3.0 million in 2026.
- According to Business Quant data, Operating Income over the past three periods registered $3.0 million, $14.0 million, and $2.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 652.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 833.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.65 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 325.80 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -79.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 193.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 291.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | 2.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.98 Mn |
| Dec 31, 2025 | 14.03 Mn |
| Sep 30, 2025 | 2.85 Mn |
| Jun 30, 2025 | -1.09 Mn |
| Mar 31, 2025 | -16.75 Mn |
| Dec 31, 2024 | 26.38 Mn |
| Sep 30, 2024 | -1.75 Mn |
| Jun 30, 2024 | -717,248.88 |
| Mar 31, 2024 | -1.68 Mn |
| Dec 31, 2023 | -12.92 Mn |
| Sep 30, 2023 | -8.07 Mn |
| Jun 30, 2023 | -4.76 Bn |
| Dec 31, 2022 | -129.19 Mn |
| Sep 30, 2022 | -83.13 Mn |
| Jun 30, 2022 | -47.13 Mn |
| Mar 31, 2022 | -57.14 Mn |
| Dec 31, 2021 | -44.26 Mn |
| Sep 30, 2021 | -31.28 Mn |
| Jun 30, 2021 | -41.07 Mn |
| Mar 31, 2021 | -112.95 Mn |